Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2017-09-04 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2017
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 August 2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure, including share issuance, options exercised, and other equity movements. There is no indication of financial performance data, earnings, management commentary, or regulatory certifications. The document is a regulatory filing reporting share capital movements for a specific month, consistent with a capital or financing update. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed data, not merely an announcement or certification, supporting this classification with high confidence.
2017-09-04 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017
Regulatory Filings Classification · 95% confidence The document is titled as a "SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017." It references a prior announcement dated 28 August 2017 about interim results. The content clarifies that no shares were bought or sold during the period, confirms compliance with corporate governance codes, and states directors' adherence to securities transaction codes. The document is short (2624 characters) and serves as a supplemental announcement rather than containing actual financial statements or substantive financial data. It does not present the interim report itself but provides additional information related to the previously announced interim results. According to the "MENU VS MEAL" rule, this is an announcement related to a report, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2017-08-29 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2017
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2017' and contains detailed financial data, including revenue, expenses, and segment performance for the six-month period ending June 30, 2017. It includes unaudited condensed consolidated interim results, management discussion and analysis, and financial highlights. The presence of actual financial figures and substantive analysis for a period shorter than a full fiscal year clearly indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). H1 2017
2017-08-28 English
FORM OF PROXY
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use by shareholders at an extraordinary general meeting (EGM) of Uni-Bio Science Group Limited. It includes instructions for appointing a proxy to vote on resolutions related to subscription agreements, issuance of warrants, and shares. The document is not a report itself but a voting proxy form related to a shareholder meeting. It does not contain financial statements or detailed financial data. It is not an announcement of voting results but the form used to cast votes. Therefore, it fits best under the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2017-08-23 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Uni-Bio Science Group Limited. It includes details about the meeting date, location, agenda items (approval of subscription agreements, issuance of warrants and shares), and procedural notes for shareholders. There are no financial statements, management discussion, or detailed financial data present. The document is a formal announcement inviting shareholders to vote on specific resolutions at the EGM. This fits the category of a Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the meeting resolutions. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a simple announcement of a report publication. Therefore, the correct classification is PSI with high confidence.
2017-08-23 English
PROPOSED ISSUE OF SHARES AND PROPOSED ISSUE OF UNLISTED WARRANTS UNDER SPECIFIC MANDATE AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Capital/Financing Update Classification · 95% confidence The document is a circular from Uni-Bio Science Group Limited regarding a proposed issue of shares and unlisted warrants under a specific mandate, and it includes a notice of an Extraordinary General Meeting (EGM). The content includes detailed information about subscription agreements, share issuance, warrant exercise prices, and meeting logistics. It is not a full financial report but rather a detailed shareholder communication about capital raising and related corporate actions. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length and detail confirm it is not a brief announcement or proxy solicitation but a substantive update on financing activities.
2017-08-23 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.